CSF Live

Forum LIVE: Targeting BTK in Rheumatology

2nd November 2022

- John Isaacs (Chair)
- Edward Vital: The Bruton’s Tyrosine Kinase pathway – an attractive target in autoimmune disease?
- David Isenberg: Targeting the BTK pathway in SLE
- Stanley Cohen: Targeting the BTK pathway in RA

Forum LIVE: The role of JAK inhibitors in the treatment algorithm

5th October 2022

- Professor Ernest Choy (Chair)
- Professor Chris Edwards: Use of JAKi as the first advanced therapy and post-biologic
- Professor Rieke Alten: Real world data on the use of JAKi (JAKPOT study)

ForumLIVE: The evolution of targeted therapies from biologics to small molecules

7th September 2022

- Professor Peter Taylor: Interpreting clinical study designs
- Professor Rieke Alten: Endpoints
- All: How well does real world experience meet clinical trial expectation

Forum LIVE: Rationale for Treatment Selections in Inflammatory Arthritis

6th July 2022

- Professor Janet Pope: Rheumatoid Arthritis
- Professor Philip Mease: Psoriatic Arthritis
- Professor Eric Ruderman: Axial Spondyloarthritis

Forum LIVE: Precision Medicine in Rheumatoid Arthritis

15th June 2022

- Dr Grace Wright (Chair)
- Professor Ernest Choy: Precision Medicine in Rheumatoid Arthritis
- Professor Jeffrey Curtis: Precision Medicine for Rheumatoid Arthritis Patients

Forum Live - Inhibiting Cytokine Signalling Pathways: Similarities and Differences

2nd May 2022

- Professors Peter Nash: JAK Selectivity
- Professor John Issac: Mechanisms of JAK inhibitors: the same or different?